Medicamen Biotech Q3FY22 consolidated net profit slides QoQ to Rs. 3.77 crore

MEDICAMEN BIOTECH LTD. has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 33.4684 crores during the period ended December 31, 2021 as compared to Rs. 32.9965 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 3.7785 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 4.2218 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 3.09 for the period ended December 31, 2021 as compared to Rs. 3.46 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 33.4684 crs	₹32.9965 crs	1.43%
Net Profit	₹3.7785 crs	₹4.2218 crs	-10.50%
EPS	₹3.09	₹3.46	-10.69%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 33.4684 crores during the period ended December 31, 2021 as compared to Rs.32.9228 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.3.7785 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.3.0147 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.3.09 for the period ended December 31, 2021 as compared to Rs.2.47 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 33.4684 crs	₹32.9228 crs	1.66%
Net Profit	₹3.7785 crs	₹3.0147 crs	25.34%
EPS	₹3.09	₹2.47	25.10%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.94.0739 crores during the 9 Months period ended December 31, 2021 as compared to Rs.91.6941 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.12.1517 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.8.4825 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.9.95 for the 9 Months period ended December 31, 2021 as compared to Rs.6.94 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹94.0739 crs	₹91.6941 crs	2.60%
Net Profit	₹12.1517 crs	₹8.4825 crs	43.26%
EPS	₹9.95	₹6.94	43.37%

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 848.30 as compared to the previous close of Rs. 873.95. The total number of shares traded during the day was 5895 in over 712 trades.

The stock hit an intraday high of Rs. 897.00 and intraday low of 814.45. The net turnover during the day was Rs. 5009364.00.

Source : Equity Bulls

Keywords

MedicamenBiotech Q3FY22 9MFY22 ResultUpdate